Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of HCC

Hepatocellular carcinoma (HCC) is the fifth most commonly diagnosed cancer and the second most common cause of cancer-related death worldwide. Sorafenib (Sora) is used as a targeted therapy for HCC treatment. Mesenchymal stem cells (MSCs) are applied as a new approach to fight malignancies. Drug res...

Full description

Bibliographic Details
Main Authors: Saieh Hajighasemlou, Mohsen Nikbakht, Saeedreza Pakzad, Samad Muhammadnejad, Safoora Gharibzadeh, Milad Mirmoghtadaei, Fariba Zafari, Iman Seyhoun, Jafar Ai, Javad Verdi
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Evidence-Based Complementary and Alternative Medicine
Online Access:http://dx.doi.org/10.1155/2020/9602728